-
-
-
-
-
-
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
-
-
-
-
-
-
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
-
-
-
-
-
-
-
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
-
-
-
-
-
-
-
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
-
-
-
-
-
-
-
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements
-
-
-
-
-
-
-
Relief Therapeutics to Participate in January Investor Meetings
-
-
-
-
-
-
-
Relief Therapeutics to Participate in January Investor Meetings
-
729 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

